Pimyupa Manaswiyoungkul

Author

University of Toronto ORCID

Also Known As

Manaswiyoungkul, Pimyupa, Pimyupa Manaswiyoungkul

Publications

360

Citations

H-Index

Concepts

All Affiliations

University of Toronto University of Veterinary Medicine Vienna Medical University of Vienna Cologne Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases Heidelberg University

About

Pimyupa Manaswiyoungkul is an author at University of Toronto specializing in medicine, natural sciences, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	104
2	Natural Sciences	3	3	64
3	Biochemistry	3	3	64
4	Health Sciences	1	1	40
5	Biomolecular Engineering	1	1	38

Pimyupa Manaswiyoungkul

Publications

331

Citations

H-Index

Page 1

	Year	Citations
Structural and functional consequences of the STAT5BN642H driver mutation Elvin D. de Araujo, Fettah Erdogan, Heidi A. Neubauer, Nature Communications	2019	83
Development of HDAC Inhibitors Exhibiting Therapeutic Potential in T-Cell Prolymphocytic Leukemia Krimo Toutah, Nabanita Nawar, Sanna Timonen, Journal of Medicinal Chemistry	2021	43
PTG-0861: A novel HDAC6-selective inhibitor as a therapeutic strategy in acute myeloid leukaemia Justyna M. Gawel, Andrew E. Shouksmith, Yasir S. Raouf, European Journal of Medicinal Chemistry Hematological MalignancyOncologyMedicineMixed-phenotype Acute LeukemiaHematology	2020	40
Characterization of Conformationally Constrained Benzanilide Scaffolds for Potent and Selective HDAC8 Targeting Muhammad Murtaza Hassan, Johan Israelian, Nabanita Nawar, Journal of Medicinal Chemistry Combinatorial ChemistryHistone DeacetylasesMedicinal ChemistryDrug TargetFavors Hdac8 Selectivity	2020	38
Discovery of HDAC6-Selective Inhibitor NN-390 with <i>in Vitro</i> Efficacy in Group 3 Medulloblastoma Nabanita Nawar, Shazreh Bukhari, Ashley Adile, Journal of Medicinal Chemistry	2022	29
Unique Molecular Interaction with the Histone Deacetylase 6 Catalytic Tunnel: Crystallographic and Biological Characterization of a Model Chemotype Olasunkanmi O. Olaoye, P. R. Watson, Nabanita Nawar, Journal of Medicinal Chemistry	2021	26
Blocking <scp>STAT3</scp> /5 through direct or upstream kinase targeting in leukemic cutaneous T‐cell lymphoma Helena Sorger, Saptaswa Dey, Pablo Vieyra-Garcia, EMBO Molecular Medicine	2022	26
Class I/IIb-Selective HDAC Inhibitor Exhibits Oral Bioavailability and Therapeutic Efficacy in Acute Myeloid Leukemia Andrew E. Shouksmith, Justyna M. Gawel, Nabanita Nawar, ACS Medicinal Chemistry Letters	2019	20
High-throughput thermofluor-based assays for inhibitor screening of STAT SH2 domains Elvin D. de Araujo, Pimyupa Manaswiyoungkul, Johan Israelian, Journal of Pharmaceutical and Biomedical Analysis BiochemistryMedicineNatural SciencesBioanalysisPharmacology	2017	16
A functional in vitro assay for screening inhibitors of STAT5B phosphorylation Elvin D. de Araujo, Pimyupa Manaswiyoungkul, Fettah Erdogan, Journal of Pharmaceutical and Biomedical Analysis Drug TargetBiochemistryMedicineNatural SciencesBioanalysis	2018	10

Page 1